Jonathan Knikman

In May 2018, I joined the group of Jos Beijnen as a PhD student. Here, my main project focuses on improving the safety of fluoropyrimidines by combined upfront genotyping and phenotyping of the DPYD gene and DPD enzyme, respectively. In addition, I also study the combination of a SHP2-inhibitor and ERK-inhibitor for the treatment of KRAS mutated pancreatic cancer.